Expert Insights
Channels
Themes
Active ETFs
ETF Strategist
Artificial Intelligence
ETF Yield
Beyond Basic Beta
Financial Literacy
China Insights
Fixed Income
Climate Insights
Free Cash Flow
Core Strategies
Innovative ETFs
Crypto
Institutional Income Strategies
Disruptive Technology
Leveraged & Inverse
Energy Infrastructure
Modern Alpha
ETF Building Blocks
Portfolio Construction
ETF Education
Tax Efficient Income
ETF Investing
Asset Class
Equity
Emerging Market Equities
Int'l Developed
U.S. Equity
Fixed Income
High Yield Corporates
Int'l Fixed Income
Investment Grade Corporates
US Treasuries & TIPS
Alternatives
Commodities
Currency
Gold/Silver/Critical Minerals
Volatility
ETF Ecosystem
ETFs in Canada
Market Outlook
Exchange
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA - iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX - VanEck Vectors Gold Miners ETF
XLF - Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV - Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
Education & Media
Newsletter
New ETFs
Education Central
Videos
ETF of the Week Podcast
ETF Prime Podcast
Gaining Perspective
ETF 360 Video Series
Exchange
Events
Exchange
Fixed Income Symposium 2024
Equity Symposium 2024
Cryptocurrency Symposium
Market Outlook Symposium
Alternatives Symposium
Income Strategy Symposium
Equity Symposium 2023
AI Symposium
Fixed Income Symposium
Company
About VettaFi
Get VettaFi’ed
IBB
Featured
Biotech ETFs: Orexigen Hit By Regulatory Hammer
By
Tom Lydon
June 3, 2011
Featured
Teva, Cephalon Boost Biotech ETFs
By
John Spence
May 2, 2011
Featured
Biogen Earnings, Drug Data to Lift Biotech ETFs
By
John Spence
April 21, 2011
Featured
ETFs And A Global Approach Help Investors Access Biotech
By
Tom Lydon
March 11, 2011
Featured
5 Biotechnology ETFs to Play Innovation
By
Tom Lydon
February 22, 2011
Featured
Sector ETFs to Play the State of the Union Address
By
Tom Lydon
January 26, 2011
Featured
Dissipate the Risk In Biotechnology With ETFs
By
Tom Lydon
January 18, 2011
Featured
Play the Booming Biotech Sector With ETFs
By
Tom Lydon
December 21, 2010
Alternative ETFs
What ETFs Are Doing Ahead of Fed Meeting
By
Tom Lydon
December 14, 2010
Featured
Why Health Care ETFs May Be In the Clear
By
Tom Lydon
November 10, 2010
Featured
Biotech ETFs May Soon Face Challenges
By
Tom Lydon
November 6, 2010
Featured
Biotech ETFs Readying to Deliver the Goods
By
Tom Lydon
November 2, 2010
Featured
5 Things That Drive Biotech ETFs
By
Tom Lydon
October 21, 2010
Featured
Biotech ETFs:The Better Way to Play
By
Tom Lydon
October 11, 2010
Featured
Biotech ETFs: 5 Ways to Play Innovation
By
Tom Lydon
August 8, 2010
Featured
Biotech ETFs Feeling the Winds of Change
By
Tom Lydon
July 26, 2010
Featured
5 Biotech ETFs If You’re Bullish
By
Tom Lydon
June 25, 2010
Featured
Biotech’s ‘Super Bowl’ Could Spark a Biotech ETF Run
By
Tom Lydon
June 4, 2010
Previous
1
…
19
20
21
22
23
Next
X